ArticleJournal of cachexia, sarcopenia and muscle2026
Higher Grip Strength Is Associated With Reduced Risk of Incident Symptomatic Hand Osteoarthritis: Data From Two Cohort Studies.
Article in Journal of cachexia, sarcopenia and muscle, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundGrip strength is increasingly recognized as a modifiable and easily measurable protective factor against chronic diseases. Lower grip strength may compromise joint stability, predisposing periarticular tissues to local inflammation, which has been implicated in hand osteoarthritis (HOA), a condition affecting approximately 189 million people globally and imposing substantial health and socio-economic burden. Whether lower grip strength is a risk factor for clinically relevant symptomatic HOA remains unclear. We aimed to examine the association between grip strength and incident symptomatic HOA to inform targeted preventive strategies.
methodsWe conducted prospective cohort studies and Mendelian randomization analyses using data from the Xiangya Osteoarthritis (XO) Study and UK Biobank. Individuals without baseline symptomatic or hospital-diagnosed HOA were included. Genetic instruments for grip strength were derived from genome-wide association studies. Symptomatic HOA in the XO Study was defined as the presence of radiographic HOA with symptoms, whereas hospital-diagnosed HOA in the UK Biobank was ascertained through hospital inpatient records.
resultsAmong 2869 XO Study participants (5461 hands; 55.9% women; mean age of 63.2 years), 166 (3.0%) hands developed incident symptomatic HOA during a mean follow-up of 3.7 years. Compared with the lowest grip strength quartile, odds ratios (ORs) and their corresponding 95% confidence intervals (95% CIs) of symptomatic HOA in the second, third and highest quartiles were 0.51 (95% CI, 0.31-0.84), 0.62 (95% CI, 0.39-0.99) and 0.46 (95% CI, 0.28-0.75), respectively (p for trend = 0.003). Similar associations were observed among 481 582 UK Biobank individuals (54.2% women; mean age of 56.4 years). Mendelian randomization analyses showed ORs of genetically determined grip strength of 0.56 (95% CI, 0.40-0.78, p < 0.001) for incident symptomatic HOA in the XO Study and 0.37 (95% CI, 0.25-0.56, p < 0.001) for incident hospital-diagnosed HOA in the UK Biobank.
conclusionsHigher grip strength was associated with a lower risk of incident symptomatic HOA. These findings offer empirical evidence that interventions aimed at enhancing grip strength may help prevent symptomatic HOA and reduce its individual and societal burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.